Focus:
News
-
9 April 2020
Novavax to commence human trial for Covid-19 vaccine
Biotechnology firm Novavax is set to start the human clinical trial of a Covid-19 vaccine candidate called NVX-CoV2373 in May.
-
9 April 2020
Regulatory delays imminent due to the coronavirus outbreak: Poll
The likelihood of regulatory delays as a consequence of the coronavirus outbreak is high, according to a recent poll conducted by Verdict.
-
9 April 2020
Coronavirus outbreak likely to cause clinical trial delays: Poll
Clinical trials, which are conducted in laboratories and designated centres, require the presence of professionals and constant monitoring of the enrolled subjects.
-
9 April 2020
OncoImmune gets approval to trial CD24Fc for Covid-19 in US
The US Food and Drug Administration (FDA) has granted approval for OncoImmune to conduct a Phase III clinical trial of CD24Fc to treat patients hospitalised with Covid-19.
-
8 April 2020
Zelira Therapeutics’ cannabis trial meets goals for insomnia
Zelira Therapeutics has reported positive data from the Phase Ia/IIb clinical trial of medicinal cannabis for the treatment of insomnia.
-
8 April 2020
Covid-19: IQVIA launches registry and trial matching tool
Life sciences services provider IQVIA has introduced an open Covid-19 registry platform and technology-powered trial matching solution
-
8 April 2020
Queen’s University Belfast trials cell therapy for coronavirus
Queen’s University Belfast researchers are conducting a clinical trial of a cell therapy to treat acute respiratory distress syndrome (ARDS) associated with Covid-19 coronavirus infection.
-
7 April 2020
Immunomedics stops Phase III breast cancer study early
Biopharmaceutical company Immunomedics has stopped the confirmatory Phase III ASCENT clinical trial of sacituzumab govitecan early after obtaining encouraging efficacy data in metastatic triple-negative breast cancer (mTNBC) patients.
-
7 April 2020
Lancaster University reports positive data for HIV drugs in Covid-19
A statistician at Lancaster University in the UK has revealed positive results from a randomised clinical trial conducted in China to assess HIV drugs lopinavir and ritonavir for alleviating Covid-19...
-
7 April 2020
Inovio commences Phase I trial of DNA vaccine for Covid-19
Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application of its DNA vaccine candidate INO-4800 against Covid-19.